Search Count: 46
 |
Crystal Structure Of Menin In Complex With Inhibitor Compound 15
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.90 Å Release Date: 2025-01-15 Classification: PROTEIN BINDING/INHIBITOR Ligands: A1AVE |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2025-01-15
Ligands: A1AVE
 |
Crystal Structure Of Menin In Complex With Inhibitor Compound 26
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.85 Å Release Date: 2025-01-15 Classification: PROTEIN BINDING/INHIBITOR Ligands: A1AVF, K, EPE, SO4 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2025-01-15
Ligands: A1AVF, K, EPE, SO4
 |
Crystal Structure Of Menin In Complex With Inhibitor Compound 20
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.98 Å Release Date: 2025-01-15 Classification: PROTEIN BINDING/INHIBITOR Ligands: A1AVG |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2025-01-15
Ligands: A1AVG
 |
Crystal Structure Of Gdp-Bound Human M-Ras Protein In Crystal Form I
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.96 Å Release Date: 2024-09-11 Classification: HYDROLASE Ligands: MG, GDP, GOL |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2024-09-11
Ligands: MG, GDP, GOL
 |
Crystal Structure Of Gdp-Bound Human M-Ras Protein In Crystal Form Ii
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.27 Å Release Date: 2024-09-11 Classification: HYDROLASE Ligands: MG, GDP, PGE, PG4, PEG |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2024-09-11
Ligands: MG, GDP, PGE, PG4, PEG
 |
Crystal Structure Of Human Ptpn2 Catalytic Domain
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.05 Å Release Date: 2024-09-04 Classification: HYDROLASE |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2024-09-04
 |
Crystal Structure Of Human Ptpn2 In Complex With Active Site Inhibitor
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.36 Å Release Date: 2024-09-04 Classification: HYDROLASE/INHIBITOR Ligands: 527 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2024-09-04
Ligands: 527
 |
Crystal Structure Of Human Ptpn2 In Complex With Allosteric Inhibitor
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.43 Å Release Date: 2024-09-04 Classification: HYDROLASE/INHIBITOR Ligands: FRJ |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2024-09-04
Ligands: FRJ
 |
Structure Of M66I Mutant Of Disulfide Stabilized Hiv-1 Ca Hexamer In Complex With Cpsf6 Peptide And Ip6
Organism: Human immunodeficiency virus 1, Homo sapiens
Method: X-RAY DIFFRACTION Resolution:3.30 Å Release Date: 2024-03-13 Classification: VIRAL PROTEIN Ligands: IHP |
Organism: Human immunodeficiency virus 1, Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2024-03-13
Ligands: IHP
 |
Structure Of M66I Mutant Of Disulfide Stabilized Hiv-1 Ca Hexamer
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Resolution:2.29 Å Release Date: 2022-11-02 Classification: VIRAL PROTEIN Ligands: IOD, CL |
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION
Release Date: 2022-11-02
Ligands: IOD, CL
 |
Disulfide Stabilized Hiv-1 Ca Hexamer In Complex With Capsid Inhibitor N-(1-(3-(4-Chloro-1-Methyl-3-(Methylsulfonamido)-1H-Indazol-7-Yl)-4-Oxo-3,4-Dihydropyrido[2,3-D]Pyrimidin-2-Yl)-2-(3,5-Difluorophenyl)Ethyl)-2-(3-(Trifluoromethyl)-4,5,6,7-Tetrahydro-1H-Indazol-1-Yl)Acetamide
Organism: Human immunodeficiency virus type 1 group m subtype b (isolate bh10)
Method: X-RAY DIFFRACTION Resolution:2.39 Å Release Date: 2022-10-05 Classification: VIRAL PROTEIN Ligands: 9VI, IOD, CL |
Organism: Human immunodeficiency virus type 1 group m subtype b (isolate bh10)
Method: X-RAY DIFFRACTION
Release Date: 2022-10-05
Ligands: 9VI, IOD, CL
 |
Disulfide Stabilized Hiv-1 Ca Hexamer In Complex With Capsid Inhibitor N-(1-(3-(4-Chloro-1-Methyl-3-(Methylsulfonamido)-1H-Indazol-7-Yl)-4-Oxo-3,4-Dihydropyrido[2,3-D]Pyrimidin-2-Yl)-2-(3,5-Difluorophenyl)Ethyl)-2-(3-(Difluoromethyl)-5,6-Dihydrocyclopenta[C]Pyrazol-1(4H)-Yl)Acetamide
Organism: Human immunodeficiency virus type 1 group m subtype b (isolate bh10)
Method: X-RAY DIFFRACTION Resolution:2.37 Å Release Date: 2022-10-05 Classification: VIRAL PROTEIN Ligands: IOD, 9WW, CL |
Organism: Human immunodeficiency virus type 1 group m subtype b (isolate bh10)
Method: X-RAY DIFFRACTION
Release Date: 2022-10-05
Ligands: IOD, 9WW, CL
 |
Structure Of Q67H Mutant Of Disulfide Stabilized Hiv-1 Ca Hexamer
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Resolution:2.15 Å Release Date: 2022-09-28 Classification: VIRAL PROTEIN Ligands: IOD, CL |
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION
Release Date: 2022-09-28
Ligands: IOD, CL
 |
Hexamer Hiv-1 Ca In Complex With Cpsf6 Peptide And Ip6 Ligand
Organism: Human immunodeficiency virus type 1 group m subtype b (isolate bh10), Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Resolution:2.81 Å Release Date: 2022-09-07 Classification: VIRAL PROTEIN Ligands: IHP, CL |
Organism: Human immunodeficiency virus type 1 group m subtype b (isolate bh10), Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION
Release Date: 2022-09-07
Ligands: IHP, CL
 |
Disulfide Stabilized Hiv-1 Ca Hexamer In Complex With Capsid Inhibitor (S)-N-(1-(3-(4-Chloro-3-(Methylsulfonamido)-1-(2,2,2-Trifluoroethyl)-1H-Indazol-7-Yl)-6-(3-Methyl-3-(Methylsulfonyl)But-1-Yn-1-Yl)Pyridin-2-Yl)-2-(3,5-Difluorophenyl)Ethyl)-2-(3-(Trifluoromethyl)-4,5,6,7-Tetrahydro-1H-Indazol-1-Yl)Acetamide
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Resolution:2.27 Å Release Date: 2022-08-03 Classification: VIRAL PROTEIN Ligands: 61F, IOD, CL |
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION
Release Date: 2022-08-03
Ligands: 61F, IOD, CL
 |
Structure Of N74D Mutant Of Disulfide Stabilized Hiv-1 Ca Hexamer
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Resolution:1.97 Å Release Date: 2022-08-03 Classification: VIRAL PROTEIN Ligands: IOD, CL |
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION
Release Date: 2022-08-03
Ligands: IOD, CL
 |
Structure Of Q67H/N74D Mutant Of Disulfide Stabilized Hiv-1 Ca Hexamer
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Resolution:2.16 Å Release Date: 2022-07-27 Classification: Viral Protein/Inhibitor Ligands: IOD, CL |
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION
Release Date: 2022-07-27
Ligands: IOD, CL
 |
Co-Crystal Structure Of Q67H Mutant Of Disulfide Stabilized Hiv-1 Ca Hexamer And Lenacapavir
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Resolution:2.46 Å Release Date: 2022-07-27 Classification: Viral Protein/Inhibitor Ligands: QNG, IOD, CL |
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION
Release Date: 2022-07-27
Ligands: QNG, IOD, CL
 |
Co-Crystal Structure Of Lenacapavir Bound To Q67H/N74D Mutant Of Disulfide Stabilized Hiv-1 Ca Hexamer
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Resolution:2.32 Å Release Date: 2022-07-27 Classification: Viral Protein/Inhibitor Ligands: QNG, CL, IOD |
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION
Release Date: 2022-07-27
Ligands: QNG, CL, IOD
 |
Co-Crystal Structure Of Lenacapavir Bound To N74D Mutant Of Disulfide Stabilized Hiv-1 Ca Hexamer
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Resolution:3.32 Å Release Date: 2022-07-27 Classification: Viral Protein/Inhibitor Ligands: QNG, CL, IOD |
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION
Release Date: 2022-07-27
Ligands: QNG, CL, IOD